Relaxin-3 vs TLQP-21 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Relaxin-3 (also called INSL7) is the most ancient member of the insulin/relaxin superfamily and is expressed predominantly in the nucleus incertus (NI) of the brainstem, a structure implicated in stress, arousal, and hippocampal theta rhythm generation. Unlike relaxin-1 and relax...
Calculate Relaxin-3 dose →TLQP-21 is a 21-amino acid peptide derived from the C-terminal region of VGF (Nerve Growth Factor-Inducible), a large precursor neuropeptide that is proteolytically cleaved into multiple bioactive fragments. VGF is strongly induced by NGF and BDNF and plays roles in energy homeos...
Calculate TLQP-21 dose →| Parameter | Relaxin-3 | TLQP-21 |
|---|---|---|
| Category | Neuropeptide | Neuropeptide |
| Research | Preclinical Research | Research |
| Half-Life | ~30-60 minutes (estimated) | Unknown |
| Typical Dose | 100-500 pmol ICV; 1-3 nmol/kg SC | 1-100 nmol (animal) |
| Frequency | Single or twice daily (preclinical) | Variable |
| Route | ICV, SC (preclinical) | Intrathecal, Subcutaneous, Intracerebroventricular |
| FDA Status | Research compound | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.